|
PPWD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62903024403249E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64209756903233E-11 |
| Normal-vs-Stage2 |
1.2335998889057E-10 |
| Normal-vs-Stage3 |
2.75002243199651E-13 |
| Normal-vs-Stage4 |
1.33480004826936E-09 |
| Stage1-vs-Stage2 |
1.517900E-02 |
| Stage1-vs-Stage3 |
1.757800E-02 |
| Stage1-vs-Stage4 |
1.799650E-01 |
| Stage2-vs-Stage3 |
5.306400E-01 |
| Stage2-vs-Stage4 |
3.610000E-01 |
| Stage3-vs-Stage4 |
6.655200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.37507799486048E-14 |
| Normal-vs-AfricanAmerican |
1.57625999999134E-05 |
| Normal-vs-Asian |
5.381900E-04 |
| Caucasian-vs-AfricanAmerican |
8.347000E-01 |
| Caucasian-vs-Asian |
8.880000E-03 |
| AfricanAmerican-vs-Asian |
1.346800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.12416759129519E-13 |
| Normal-vs-Female |
1.78468351208494E-12 |
| Male-vs-Female |
5.960600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.64659455146466E-11 |
| Normal-vs-Age(41-60Yrs) |
6.55087095680074E-12 |
| Normal-vs-Age(61-80Yrs) |
1.68653979670808E-12 |
| Normal-vs-Age(81-100Yrs) |
2.978200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.045580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.322600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.622800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.318180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.294600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.401400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.138600E-03 |
| Classical-VS-Follicular |
5.784000E-04 |
| Classical-VS-Other |
7.632600E-01 |
| Classical-VS-Normal |
1.94160243438546E-11 |
| Tall-VS-Follicular |
7.372200E-01 |
| Tall-VS-Other |
2.142200E-01 |
| Tall-VS-Normal |
7.80549958001586E-10 |
| Follicular-VS-Other |
3.908800E-01 |
| Follicular-VS-Normal |
8.07476308040123E-12 |
| Other-VS-Normal |
1.168000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.2410519540681E-14 |
| Normal-vs-N1 |
1.08129999998319E-06 |
| N0-vs-N1 |
1.183360E-01 |
|
|
